Evaluating viscum album in tumour eradication strategies. Extracts from the plant parasite mistletoe are, internationally, the most widely used complementary cancer treatments. Providing clear evidence-based research, this project will focus on enhancing mistletoe anti-cancer treatment through the development of novel liposome-based tumour therapies.
Thermal transport by design for fast and efficient solar thermochemical fuel production. This project aims to demonstrate the utility of the thermal transport by design approach to develop functionally graded reactive materials that allow for fast and efficient solar thermo-chemical fuel production. Prediction capabilities will be developed to optimise multi-scale radiative and gas transport coupled with non-stoichiometric redox reactions. Synthesis gas production will be demonstrated using the ....Thermal transport by design for fast and efficient solar thermochemical fuel production. This project aims to demonstrate the utility of the thermal transport by design approach to develop functionally graded reactive materials that allow for fast and efficient solar thermo-chemical fuel production. Prediction capabilities will be developed to optimise multi-scale radiative and gas transport coupled with non-stoichiometric redox reactions. Synthesis gas production will be demonstrated using the new structures in a prototype solar thermochemical reactor under high-flux irradiation. This project aims to advance the fields of thermal sciences and high-temperature solar thermochemical processing and expand the engineering knowledge base to pave the way to sustainable transportation with the existing infrastructure.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC200100023
Funder
Australian Research Council
Funding Amount
$4,920,490.00
Summary
ARC Training Centre for The Global Hydrogen Economy. The centre aims to transform Australia into a hydrogen powerhouse by building enabling capacity in hydrogen innovation in a short timeframe. Australia is well-positioned to capitalise on the emerging global growth of hydrogen, however to be competitive and produce at scale, we need cost-effective hydrogen technologies and capabilities for transitioning hydrogen into industries. This innovative, five-year program will generate new technologies ....ARC Training Centre for The Global Hydrogen Economy. The centre aims to transform Australia into a hydrogen powerhouse by building enabling capacity in hydrogen innovation in a short timeframe. Australia is well-positioned to capitalise on the emerging global growth of hydrogen, however to be competitive and produce at scale, we need cost-effective hydrogen technologies and capabilities for transitioning hydrogen into industries. This innovative, five-year program will generate new technologies and equip a future workforce of industry-focused engineers with advanced skills for development and scaling-up of hydrogen generation and transport. Benefits include: export of hydrogen fuel and advanced technologies; job creation; and a lower emissions domestic energy industry.Read moreRead less
We have discovered a single tumour factor which causes cancer cachexia, a wasting condition that is one of the worst complications of malignancy, for which there is no current effective treatment. We have developed antibodies which effectively block this condition in preclinical models and have produced human/humanised version of this. This application is to characterise these human antibodies to allow us proceed to clinical trials.
Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.
Melanotransferrin: A “Missing Link” And A Novel Pharmacological Target For Treatment
Funder
National Health and Medical Research Council
Funding Amount
$613,848.00
Summary
Despite >30 years of research, the precise function of the protein, melanotransferrin (MTf), is unknown. However, we have breakthrough evidence that MTf stimulates WNT signalling as a major driver in cancer progression. We will investigate this hypothesis, which will underpin new cancer therapies. Indeed, we designed a new class of drugs that target the WNT pathway via up-regulating the WNT inhibitor, NDRG1. This drug (DpC) inhibits MTf expression to block tumour cell growth and metastasis.
Griseofulvin, A Novel Host-directed Antimalarial Drug
Funder
National Health and Medical Research Council
Funding Amount
$461,551.00
Summary
This grant is for a Phase II clinical trial to test an FDA & TGA approved drug for a new use as an antimalarial drug. The parasite uses an enzyme from the human RBC to help it replicate & early trials show this drug appears to disrupt the life cycle of the parasite. This Phase II clinical trial will test the drug on human subjects, & if successful, the drug will be a new and novel way in which to treat and prevent malarial infections in humans.
Production, processing and combustion of an innovative slurry fuel for high efficiency distributed power generation. This project will advance the science underpinning the development of an innovative technology for energy production (with carbon capture) and use in remote regions. The outcomes of this research will help meet the great challenges of climate change and contribute to the development of an environmentally sustainable Australia.
Low emission road transportation: harnessing the potential of alternative fuels and advanced vehicle technologies through online optimisation. This project will develop fundamental mathematical theory and use it to enable the best possible CO2 reduction capability in road vehicles. The cost of different technologies and fuels will then be compared to determine the most cost effective approaches to reduce road transport emissions.